XSUS:CA:TSX-iShares ESG MSCI USA Index (CAD)

ETF | US Equity |

Last Closing

CAD 42.74

Change

-0.08 (-0.19)%

Market Cap

CAD 0.59B

Volume

1.82K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-20 )

Largest Industry Peers for US Equity

Symbol Name Price(Change) Market Cap
VFV:CA Vanguard S&P 500 Index ETF

-0.53 (-0.37%)

CAD 21.96B
ZSP:CA BMO S&P 500

-0.27 (-0.30%)

CAD 18.70B
XSP:CA iShares Core S&P 500 (CAD Hedg..

-0.15 (-0.26%)

CAD 11.35B
VUN:CA Vanguard US Total Market

-0.31 (-0.29%)

CAD 11.29B
XUS:CA iShares Core S&P 500 Index ETF

-0.19 (-0.38%)

CAD 8.82B
HXS:CA Global X S&P 500 Corporate Cla..

-0.29 (-0.35%)

CAD 4.70B
VSP:CA Vanguard S&P 500 CAD hedged

-0.23 (-0.25%)

CAD 4.14B
QUU:CA Mackenzie US Large Cap Equity ..

-1.58 (-0.67%)

CAD 3.65B
XUU:CA iShares Core S&P US Total Mark..

-0.08 (-0.13%)

CAD 3.46B
XQQ:CA iShares NASDAQ 100 (CAD Hedged..

-0.14 (-0.28%)

CAD 3.34B

ETFs Containing XSUS:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (US Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -4.83% 14% F 22% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -4.83% 14% F 22% F
Trailing 12 Months  
Capital Gain 13.31% 66% D+ 72% C
Dividend Return 0.98% 30% F 14% F
Total Return 14.29% 68% D+ 65% D
Trailing 5 Years  
Capital Gain 135.22% 72% C 76% C+
Dividend Return 8.59% 17% F 10% F
Total Return 143.81% 65% D 70% C-
Average Annual (5 Year Horizon)  
Capital Gain 15.39% 78% C+ 79% B-
Dividend Return 16.29% 75% C 77% C+
Total Return 0.89% 30% F 37% F
Risk Return Profile  
Volatility (Standard Deviation) 15.74% 37% F 54% F
Risk Adjusted Return 103.46% 61% D- 94% A
Market Capitalization 0.59B 53% F 62% D

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.